Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 19th May 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

WSAVA establishes new Oncology Working Group
Dr Martin Soberano (pictured) is president of the Latin American Veterinary Oncology Society and chair of the new Working Group.

Specialist committee is working to produce global guidelines for veterinary practice.

A newly inaugurated WSAVA committee aims to raise awareness of the latest thinking in veterinary oncology and promote best practice globally.

Named the WSAVA Oncology Working Group, its members include specialists from around the world, including past president of WSAVA and the Veterinary Society of Surgical Oncology Dr. Jolle Kirpensteijn.

The Committee is chaired by Argentinian veterinary surgeon and president of the Latin American Veterinary Oncology Society Dr. Martin Soberano.

The other members of the Working Group are:

  • Dr. Nick Bacon - an RCVS-recognised specialist in small animal surgery (oncology) and a European specialist in small animal surgery (oncology)
  • Dr. Pachi Clemente-Vicario – a diplomate in oncology and small animal internal medicine from the American College of Veterinary Internal Medicine (ACVIM)
  • Dr. Antonio Guiliano – a board-certified oncologist with the European College of Veterinary Internal Medicine (ECVIM)
  • Dr. Ann Hohenhaus – a diplomate in oncology and small animal internal medicine from ACVIM
  • Dr. Natalia Ignatenko – who completed her residency at the Department of Oncology Centre for Clinical Veterinary Medicine, Munich in 2017.

The members are beginning work on the development of a set of accessible global guidelines for veterinary oncology practice. While these guidelines are in development, the WSAVA Oncology Working Group will be producing practical tools to help veterinary surgeons improve standards of treatment and educate pet owners about cancer.

Dr. Soberano said: “The WSAVA Oncology Working Group aims to overcome global variations in oncology treatment and raise awareness of the different types of tumors affecting companion animals.

“Many cancers in these animals also occur in humans so we see an opportunity to improve the lives of both animal and human patients by raising standards of treatment for veterinary oncology patients.”

Images (c) WSAVA.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.